Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies
- Nectin Therapeutics Ltd., (Nectin) a biotechnology company has extended its Series A financing to over $25M for immuno-oncology therapies
Source: hitconsultant.net
Page 3 - Advanced Solid News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Advanced Solid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Advanced Solid Today - Breaking & Trending Today
Grey Wolf Therapeutics Announces Clinical Supply Agreement with Regeneron for Trial Evaluating GRWD5769 in Combination with Libtayo® (cemiplimab)
/PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer...
Source: prnewswire.com
Curis Announces Three Presentations at SITC 2022
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
Shasqi Advances SQ3370 to Phase 2 in Solid Tumors
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Investegate |NuCana plc Announcements | NuCana plc: NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022
Investegate announcements from NuCana plc, NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022
Source: investegate.co.uk